Q4 2018 Neogenomics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to this NeoGenomics Inc. Fourth Quarter and Full Year 2018 Financial Results Conference Call. As a reminder, today's meeting is being recorded. (Operator Instructions)
And now at this time, for opening remarks and introductions, I am pleased to turn the floor over to Mr. Doug VanOort. Please go ahead, sir.
Thank you, Jim. Good morning, everyone. I'd like to welcome everyone to NeoGenomics' Fourth Quarter 2018 Conference Call. Joining me from our Fort Myers headquarters is Sharon Virag, our Chief Financial Officer; Rob Shovlin, President of our Clinical Services Division; George Cardoza, President of our Pharma Services Division; and Bill Bonello, Chief Strategy and Corporate Development Officer and Director of Investor Relations.
Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |